 Gene Expression Regulation, Neoplastic
"Gene Expression Regulation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
| Descriptor ID |
D015972
|
| MeSH Number(s) |
G05.308.370
|
| Concept/Terms |
Gene Expression Regulation, Neoplastic- Gene Expression Regulation, Neoplastic
- Regulation of Gene Expression, Neoplastic
- Regulation, Gene Expression, Neoplastic
- Neoplastic Gene Expression Regulation
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Neoplastic".
This graph shows the total number of publications written about "Gene Expression Regulation, Neoplastic" by people in this website by year, and whether "Gene Expression Regulation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 1 | 4 | 5 | | 1990 | 7 | 3 | 10 | | 1991 | 6 | 7 | 13 | | 1992 | 12 | 18 | 30 | | 1993 | 9 | 11 | 20 | | 1994 | 11 | 9 | 20 | | 1995 | 13 | 16 | 29 | | 1996 | 23 | 36 | 59 | | 1997 | 29 | 20 | 49 | | 1998 | 22 | 36 | 58 | | 1999 | 30 | 36 | 66 | | 2000 | 27 | 44 | 71 | | 2001 | 27 | 67 | 94 | | 2002 | 40 | 56 | 96 | | 2003 | 53 | 82 | 135 | | 2004 | 69 | 93 | 162 | | 2005 | 95 | 91 | 186 | | 2006 | 81 | 85 | 166 | | 2007 | 93 | 112 | 205 | | 2008 | 101 | 120 | 221 | | 2009 | 80 | 121 | 201 | | 2010 | 69 | 131 | 200 | | 2011 | 80 | 165 | 245 | | 2012 | 65 | 189 | 254 | | 2013 | 93 | 177 | 270 | | 2014 | 81 | 195 | 276 | | 2015 | 85 | 189 | 274 | | 2016 | 75 | 152 | 227 | | 2017 | 78 | 177 | 255 | | 2018 | 53 | 93 | 146 | | 2019 | 7 | 13 | 20 |
To return to the timeline, click here.
Below are the most recent publications written about "Gene Expression Regulation, Neoplastic" by people in Profiles.
-
Luo J, Wang K, Yeh S, Sun Y, Liang L, Xiao Y, Xu W, Niu Y, Cheng L, Maity SN, Jiang R, Chang C. LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nat Commun. 2019 06 12; 10(1):2571.
-
Hu Q, Ye Y, Chan LC, Li Y, Liang K, Lin A, Egranov SD, Zhang Y, Xia W, Gong J, Pan Y, Chatterjee SS, Yao J, Evans KW, Nguyen TK, Park PK, Liu J, Coarfa C, Donepudi SR, Putluri V, Putluri N, Sreekumar A, Ambati CR, Hawke DH, Marks JR, Gunaratne PH, Caudle AS, Sahin AA, Hortobagyi GN, Meric-Bernstam F, Chen L, Yu D, Hung MC, Curran MA, Han L, Lin C, Yang L. Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression. Nat Immunol. 2019 07; 20(7):835-851.
-
Liu J, Wang T, Creighton CJ, Wu SP, Ray M, Janardhan KS, Willson CJ, Cho SN, Castro PD, Ittmann MM, Li JL, Davis RJ, DeMayo FJ. JNK1/2 represses Lkb1-deficiency-induced lung squamous cell carcinoma progression. Nat Commun. 2019 05 14; 10(1):2148.
-
Schefler AC, Koca E, Bernicker EH, Correa ZM. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma. Graefes Arch Clin Exp Ophthalmol. 2019 Jul; 257(7):1541-1545.
-
Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, Heymach JV, Johnson JE, Lehman JM, MacPherson D, Massion PP, Minna JD, Oliver TG, Quaranta V, Sage J, Thomas RK, Vakoc CR, Gazdar AF. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer. 2019 05; 19(5):289-297.
-
McAndrews KM, Kalluri R. Nischarin Regulates Secretion of Exosomes and Cancer Progression. Cancer Res. 2019 May 01; 79(9):2099-2101.
-
Javed Z, Muhammad Farooq H, Ullah M, Zaheer Iqbal M, Raza Q, Sadia H, Pezzani R, Salehi B, Sharifi-Rad J, Cho WC. Wnt Signaling: A Potential Therapeutic Target in Head and
Neck Squamous Cell Carcinoma Asian Pac J Cancer Prev. 2019 Apr 29; 20(4):995-1003.
-
Sprouse ML, Welte T, Boral D, Liu HN, Yin W, Vishnoi M, Goswami-Sewell D, Li L, Pei G, Jia P, Glitza-Oliva IC, Marchetti D. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling. Int J Mol Sci. 2019 Apr 18; 20(8).
-
Turato C, Scarpa M, Kotsafti A, Cappon A, Quarta S, Biasiolo A, Cavallin F, Trevellin E, Guzzardo V, Fassan M, Chiarion-Sileni V, Castoro C, Rugge M, Vettor R, Scarpa M, Pontisso P. Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity. Cancer Sci. 2019 May; 110(5):1552-1563.
-
Gao S, Wang J, Tian S, Luo J. miR-9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16. Int J Oncol. 2019 Jun; 54(6):1921-1932.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|